| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-06 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.2 | 1e-06 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.2 | 1e-06 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-06 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-06 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.28 | 2e-06 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.31 | 3e-06 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.2 | 4e-06 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.2 | 5e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.18 | 5e-06 |